Heading to Bethesda this past January for the Food and Drug Administration's (FDA) meeting on the Lyme disease vaccine LYMErix, I expected a somber and orderly affair. Instead, for the price of gas and tolls from New York, I bought a ringside seat at a raucous, riotous, and bitter free-for-all worth…
WHALE.TO
